Paper Details

  1. Home
  2. Paper Details

Clinical effect of mifepristone on patients with ovarian cancer in pregnancy.

Author: LyuYongli, ShangLili, WangYanjing

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Mifepristone combined with bevacizumab was found to be effective in treating patients with ovarian cancer, reducing bleeding and side effects compared to conventional chemotherapy.
Paper Details　
Original Abstract of the Article :
At present, the main methods of clinical treatment of ovarian cancer are cytoreductive surgery and multidrug combination chemotherapy, in which multidrug combination chemotherapy is based on platinum drugs. Mifepristone can be used as an adjuvant drug for the treatment of drug-resistant and refracto...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/30852479

データ提供：米国国立医学図書館（NLM）

Mifepristone: A Potential Adjunct in Ovarian Cancer Treatment

Imagine a vast desert landscape, where unexpected resources can emerge. This study explores the potential of mifepristone, a drug primarily known for its use in medication abortion, as an adjunct treatment for ovarian cancer. The researchers, like resourceful desert explorers, investigated the efficacy of mifepristone in combination with bevacizumab, a common anticancer drug, in treating ovarian cancer. Their findings suggest that mifepristone may enhance the effectiveness of bevacizumab, potentially improving treatment outcomes for patients with ovarian cancer. This study opens up a new avenue of research into the potential of mifepristone as a valuable tool in the fight against ovarian cancer.

Mifepristone: A New Frontier in Ovarian Cancer Treatment

This study suggests that mifepristone may have a role to play in treating ovarian cancer, potentially enhancing the effectiveness of bevacizumab. The findings open up new avenues of research into the potential of mifepristone as a valuable tool in the fight against this challenging disease.

Navigating the Desert of Ovarian Cancer: Exploring New Treatment Strategies

This study highlights the importance of exploring new treatment strategies for ovarian cancer. Just as a camel seeks out hidden springs in the desert, we must continue to research and develop innovative approaches to combat this challenging disease. The potential of mifepristone as an adjunct treatment offers a glimmer of hope for patients seeking new and effective therapies.

Dr.Camel's Conclusion

This study suggests that mifepristone may offer a promising adjunct treatment for ovarian cancer, potentially enhancing the effectiveness of bevacizumab. While further research is needed to confirm these findings, the study offers a glimmer of hope for patients seeking new and effective therapies for ovarian cancer.

Date :
  1. Date Completed 2019-09-03
  2. Date Revised 2019-09-03
Further Info :

Pubmed ID

30852479

DOI: Digital Object Identifier

30852479

Related Literature

Article Analysis
・Side Effects of mifepristone (mifeprex)
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.